Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Manufacturing capacity of next generation technology increased to 350 MW p.a. – operational in Q1 2025

HydrogenPro ASA has over a long period of time developed a unique third-generation electrode technology that enables electrolyzers to produce with industry-leading efficiency and reducing the Levelized Cost of Hydrogen. On June 24, 2024 HydrogenPro ASA announced the decision to invest in a new production line for its third-generation electrodes. The production is expected to start Q1 2025 and after optimization work, the production line will reach a capacity of about 350 MW without any additional investment needed (original investment, 70 MNOK). This has been accomplished by optimizing

OssDsign AB (publ) publishes Q2 2024 Interim Report

Reaching milestone in orthobiologics salesOssDsign AB (publ) announces that the interim report for Q2 2024 is now available as a PDF on the company’s website www.ossdsign.com/reports. A PDF version is also attached to this press release.The Q2 2024 results will also be presented at an investor webcast today August 20th at 11:00 CET. The webcast can be accessed via the following link: www.finwire.tv/webcast/ossdsign/q2-2024/ or via the OssDsign website.    The second quarter in figures   · Net sales amounted to TSEK 29,737 (23,997), corresponding to a growth of 143%, or 139%

BerGenBio Collaborates with Tempus to Potentially Accelerate Development in STK11m Non-Small Cell Lung Cancer

Bergen, Norway, August 20, 2024, – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, announced today a collaboration with Tempus, a technology company leading the adoption of AI to advance precision medicine and patient care, to advance the clinical development of BerGenBio’s selective AXL inhibitor bemcentinib in first line (1L) Non-Small Cell Lung Cancer (NSCLC) patients with STK11 mutations (STK11m). BerGenBio’s on-going BGBC016 Phase 1b/2a trial is designed to assess the benefit of

HydrogenPro ASA – Q2 2024 Results

20 August 2024 - HydrogenPro ASA (OSE: HYPRO): HydrogenPro has today reported its financial results for the second quarter. Achievements and highlights: - Decision to invest in third-generation electrode technology with a 350 MW capacity manufacturing facility in Denmark. The investment cost is stipulated to NOK 70 million.  - Awarded DKK 35 million from the Export and Investment Fund of Denmark to continue plans for a large-scale production facility for third-generation electrode technology. - Joint validation program for stack performance and operation conditions for the

Desert Control Releases Q2 2024 Report and Year-to-Date Company Update

Sandnes, Norway, 20 August 2024 — Desert Control AS (DSRT) announces its second-quarter report and interim financial results for the fiscal period ending 30 June 2024. Desert Control made significant progress in the second quarter of 2024. Technological advancements drove a record number of installations and expanded the U.S. project portfolio, while collaboration with partners advanced key regulatory and operational milestones in the Middle East.Operational Highlights: Technological Breakthroughs Drove Record Growth in Installations · Increased Production Capacity: Achieved a

Invitation to the presentation of Bakkafrost's Q2 2024 results 26 August 2024 at 8:00 am (CET)

Bakkafrost's interim report Q2 2024 will be presented at 8:00 am (CET) on 26 August 2024 at Hotel Continental, Stortingsgaten 24/26, Oslo, Norway. WEBCAST The presentation will be transmitted live on Bakkafrost's website www.bakkafrost.com. Bakkafrost´s interim report Q2 2024 and associated presentation will be released prior to market opening on 26 August 2024 at 6:00 am (CET). Contacts: · Regin Jacobsen, CEO of P/F Bakkafrost: +298 235001 (mobile) · Høgni Dahl Jakobsen, CFO of P/F Bakkafrost: +298 235060 (mobile) This information is subject of the disclosure

Africa Oil Announces Increase in Its Impact Oil & Gas Shareholding

VANCOUVER, BC, August 19, 2024 /CNW/ -  (AOI–TSX, AOI–Nasdaq-Stockholm) – Africa Oil Corp. (“Africa Oil”, or the “Company”) is pleased to provide an update on the offer to minority shareholders in Impact Oil & Gas Limited (“Impact”) announced on March 18, 2024 ( “Offer”). The Company made the Offer to acquire shares from minority shareholders in Impact conditional upon completion of the farm down transaction for Impact’s Namibia assets announced on January 10, 2024. The Company has decided to waive this condition and proceed to complete the Offer. Completion is expected to occur

Genovis Announces Strategic Divestment of Antibody Business to Leinco Technologies Inc.

Genovis, a leading innovator in enzyme technology, today announced the successful divestment of its antibody business to Leinco Technologies Inc., a globally recognized developer of high-quality antibodies for research and diagnostics. This strategic move aligns with Genovis previously communicated focus on optimizing the core business operation and enhancing profitability.The divestment follows a strategic review by Genovis, which identified the need to concentrate on its core enzyme business—a sector where the company has consistently demonstrated market leadership and profitability. The

Bulletin from the annual general meeting in EQL Pharma AB on 19 August 2024

Today, on 19 August 2024, the annual general meeting was held in EQL Pharma AB. A summary of the adopted resolutions follows below.Resolution on adoption of accounts and allocation of the company’s result The annual general meeting resolved to adopt the income statement and balance sheet as well as the consolidated income statement and the consolidated balance sheet. The annual general meeting also resolved to distribute the company’s result in accordance with the proposal from the board of directors in the annual report meaning that no dividends are paid for the financial year 2023/2024

Repurchases of shares in Hoist Finance during week 33, 2024

PRESS RELEASEStockholm 19 August 2024   During the period 12 August 2024 – 16 August 2024 Hoist Finance AB (publ) (LEI code: 549300NPK3FB2BEL4D08) (”Hoist Finance”) has repurchased in total 180,000 own shares (ISIN: SE0006887063), as part of the repurchase programme initiated by the Board of Directors. The repurchases form part of the repurchase programme of a maximum of 10 percent of the total number of shares in the company for a total amount of not more than SEK 100,000,000 that Hoist Finance announced on 25 July 2024. The repurchase programme runs during the period from

Repurchases of shares by EQT AB during week 33, 2024

Between 12 August 2024 and 16 August 2024 EQT AB (LEI code 213800U7P9GOIRKCTB34) (“EQT”) has repurchased in total 371,231 own ordinary shares (ISIN: SE0012853455).The repurchases form part of the repurchase program of a maximum of 2,000,000 own ordinary shares for a total maximum amount of SEK 1,000,000,000 that EQT announced on 27 May 2024. The repurchase program, which runs between 19 July 2024 and 23 August 2024, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 and the Commission Delegated Regulation (EU) No 2016/1052. EQT ordinary shares have been

Relais Group Plc: Share Repurchase 19.8.2024

Relais Group Plc  ANNOUNCEMENT  19.8.2024 Relais Group Plc: Share Repurchase 19.8.2024 In the Helsinki Stock Exchange Trade date           19.8.2024Bourse trade         BuyShare                  RELAISAmount             700 SharesAverage price/ share    15,0500 EURTotal cost            10 535,00 EUR Relais Group Plc now holds a total of 45 459 sharesincluding the shares repurchased on 19.8.2024 On behalf of Relais Group Plc Nordea Bank Oyj Janne

Britta Rosenqvist new Head of Sales

Britta Rosenqvist has been appointed as the new Head of Sales at Swedbank Robur. Her previous experience includes senior roles such as Head of Third Party Distribution at Avanza, Chief Product Officer for Savings & Payments at Skandiabanken, and most recently, Head of Institutional Client Solutions at Swedbank Robur.“I am very pleased to welcome Britta Rosenqvist as our new Head of Sales. She brings extensive experience and expertise in the Swedish fund and savings market, along with an impressive track record in leadership roles. Her clear and inspiring leadership will accelerate the

Holding(s) in Company

TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB0003328555 Issuer Name Fidelity Japan Trust PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name City of London Investment Management Company Limited City of registered office (if applicable) London Country of registered office (if applicable) United Kingdom 4. Details of the shareholder Full name of shareholder(s) if different from the person(s)

Heimdal and ViroSafe Partner to Strengthen Nordic Cybersecurity

COPENHAGEN, Denmark, August 19, 2024 – Heimdal, a global leader in cybersecurity, has announced a strategic partnership with ViroSafe, one of Norway’s top IT security distributors. The collaboration will expand access to advanced cybersecurity solutions across Norway.Heimdal offers the widest range of cybersecurity tools in the world that companies can use individually or as part of a complete platform, with and without a SOC, as part of the platform. All these tools are managed through a single pane of glass, giving businesses a clear, unified view of their security operations from one

#24-286 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

SALT Appoints Experienced Leader Camilla Wallin as New CEO

Stockholm, Sweden – 2024-08-19 – SALT (School of Applied Technology), a leading player in innovative tech education, is proud to announce the appointment of Camilla Wallin as its new Chief Executive Officer (CEO). This strategic recruitment marks a pivotal moment for SALT as it strengthens its leadership team and drives forward its ambitious growth plans across Europe. Camilla Wallin brings over 15 years of experience in key commercial leadership roles, including her most recent positions at Academic Work and Presto. In addition to her extensive background in talent

Transatlantic football collaborations supporting athlete and student development

Close collaborations with elite soccer clubs in the United States are giving staff and students at Teesside University the opportunity to work alongside professional footballers supporting their training and development.Sports and exercise staff from the University’s School of Health & Life Sciences recently visited the United States where they helped forge relationships with two Major League Soccer (MLS) clubs, Colorado Rapids and D.C. United. The collaborations follow the signing of a Memorandum of Understanding with David Beckham-owned MLS side Inter Miami CF 

Invitation to Observe Medical ASA's first half year 2024 presentation and Q&A

Oslo, August 19, 2024 - Observe Medical ("the Company" or "Observe Medical") will release its results for the first half year 2024 on Monday, 26 Augsut 2024. The presentation will be published on NewsWeb and the Company's website at 07:00 CET on the same day. The Company will host a presentation and Q&A session at 10:00 CET on the same day. Personal attendance is welcomed at Carnegie's offices at Aker Brygge, Fjordalleen 16. The session will also be streamed via webcast. To register and follow the presentation online, please copy and paste the following link into your browser, click

There are no items matching the current filter
There are no more items matching the current filter
Back to top